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Abstract
Traditional approaches to protein profiling were built around the concept of investigating one
protein at a time and have long since reached their limits of throughput. Here we present a
completely new approach for comprehensive compositional analysis of complex protein mixtures,
capable of overcoming the deficiencies of current proteomics techniques. The Combinatorial
methodology utilises the peptidomics approach, in which protein samples are proteolytically
digested using one or a combination of proteases prior to any assay being carried out. The second
fundamental principle is the combinatorial depletion of the crude protein digest (i.e. of the peptide
pool) by chemical crosslinking through amino acid side chains. Our approach relies on the chemical
reactivities of the amino acids and therefore the amino acid content of the peptides (i.e. their
information content) rather than their physical properties. Combinatorial peptidomics does not
use affinity reagents and relies on neither chromatography nor electrophoretic separation
techniques. It is the first generic methodology applicable to protein expression profiling, that is
independent of the physical properties of proteins and does not require any prior knowledge of
the proteins. Alternatively, a specific combinatorial strategy may be designed to analyse a particular
known protein on the basis of that protein sequence alone or, in the absence of reliable protein
sequence, even the predicted amino acid translation of an EST sequence. Combinatorial
peptidomics is especially suitable for use with high throughput micro- and nano-fluidic platforms
capable of running multiple depletion reactions in a single disposable chip.
Background
Gerardus Mulder, a Dutch chemist who was the first to
purify proteins in the middle of the 19th century, defined
them to be "without doubt the most important of all sub-
stances of the organic kingdom, and without it life on our
planet would probably not exist". However, despite more
than one and a half centuries of scientific effort, proteins
are routinely being studied using traditional technologies,
which have long since reached their limits of throughput.
Techniques such as 2D gel electrophoresis, chromatogra-
phy or a combination of the two are now widely available,
but have a number of disadvantages in that they do not
allow a highly parallel approach due to their physical lim-
itations, large sample consumption and high costs. Pro-
tein staining on gels is biased towards highly abundant
proteins and yields only qualitative information. In
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addition, in all proteomics applications based on electro-
phoretic or chromatographic separation of complex
protein mixtures, the purity of final preparations is
inversely proportional to the quantity of the materials
obtained. This means that larger amounts of highly com-
plex protein mixtures and more purification steps (or sep-
aration dimensions) are required in order to yield enough
material of sufficient purity for subsequent mass spec-
trometry (MS) or other applications. Most chromatogra-
phy based techniques suffer from poor reproducibility. An
alternative approach using isotope-coated affinity tags
(ICAT) has been developed to allow relative quantitation
of proteins by MS [1]. ICAT utilises isotope coding to
quantitate differential protein expression, but the peptide
pools obtained are too complex for convenient resolution
by MS. More recently another completely different tech-
nology has been applied for proteomics research. This
technology employs arrays of affinity ligands (antibodies
or other agents) immobilised on a variety of solid sup-
ports [2,3]. Using arrayed affinity ligands avoids the need
for protein separation, as all of the spotted reagents are
spatially separated and their positions known. The use of
fluorescently labelled protein mixtures further simplifies
protein detection. Additional increases in protein array
sensitivity and signal-to-noise ratio were reported using
time resolved fluorescence [4] and planar waveguides as
protein immobilisation substrates [5,6]. However, unlike
DNA chips, protein chip based proteomics faces signifi-
cant difficulties due to the much more heterogeneous
character of proteins compared to nucleic acids. A signifi-
cant improvement in protein microarray technology has
been achieved through the use of competitive displace-
ment strategies [7]. However, a whole cell protein reper-
toire is extremely complex and different proteins may
require different solubilisation and separation tech-
niques. The less than reproducible character of the protein
sample preparation is capable of compromising any pro-
tein assay which follows. Current state-of-the-art in pro-
tein biochemistry has not yielded universal solubilisation
and affinity assay conditions applicable to all cellular pro-
teins, e.g., small and large, hydrophobic and hydrophilic,
soluble and membrane associated, basic and acidic pro-
teins. Protein heterogeneity significantly limits the appli-
cability of affinity-based systems to small subsets of
proteins having very similar physical characteristics.
Peptidomics
We have previously shown that the composition of a pro-
tein mixture can be determined by directly assaying the
peptides from crude tryptic or otherwise digested protein
preparations using immobilised antibodies. The Peptid-
omics approach [8] resolves many of the problems associ-
ated with multiplex affinity assays (e.g. arrays of
antibodies) by allowing single optimised reaction condi-
tions to be used irrespective of the starting material (small
soluble proteins or large transmembrane receptors). This
has been achieved through proteolytic digestion of the
protein sample, for example with Trypsin. Since protein
samples are to be digested, protein solubilisation is less of
an issue and may be omitted altogether. Peptidomics ena-
bles the high throughput screening of proteins in a micro-
array format and has several advantages over affinity
capture of intact proteins. These include, the homogeneity
of digested proteins (typically in the form of tryptic pep-
tides), which results in a more uniform pool of target spe-
cies, allowing more regular quantitation. As peptides are
much more stable and robust than proteins, protein deg-
radation is not an issue. Also, antibody reagents can be
more easily generated, such as by chemical synthesis of in
silico  predicted peptides against which antibodies are
raised, e.g. by phage display techniques [9–12] or using
in-vitro evolution [13–15] and DNA-protein fusions [16–
18]. Such affinity reagents can be obtained in a truly high
throughput manner and their specificities and affinities
can be more easily controlled. In Peptidomics, each pro-
tein is broken down into many smaller components,
resulting in the availability of a range of peptides thus
allowing multiple independent assays for the same "orig-
inal" protein to be performed using most antigenic spe-
cies. Peptides are also particularly suited to detection by
mass spectrometric techniques, such as MALDI-TOF-MS
for direct analysis of samples on a solid substrate such as
microarrays. The peptide mass range is such that isotopic
resolution is easily achieved and hence their masses can
be accurately determined, allowing for mass matching
database searches to be performed to confirm the specifi-
city of the affinity capture.
Digestion of cellular fractions or even intact tissues results
in the release of peptides, which will be mostly
hydrophilic, thus further improving the assay. In contrast
to a traditional affinity assay, Peptidomics allows multiple
antibody-peptide pairs to be used to assay the same pro-
tein target (similarly to Affymetrix DNA oligonucleotide
arrays, where up to 20 oligonucleotides may be generated
against the same mRNA sequence http://www.affyme-
trix.com), thus increasing the reliability of the assay. One
of the major drawbacks of any affinity assay-based tech-
nique, including Peptidomics, is the availability and the
cost of capture agents. Unlike nucleic acids, which are
both information carriers and perfect affinity ligands,
every protein requires the production of its own unique
affinity reagent (e.g. an antibody) the development of
which, unlike the synthesis of an oligonucleotide or puri-
fication of a PCR product, may require significant
amounts of time and resources.Journal of Nanobiotechnology 2003, 1 http://www.jnanobiotechnology.com/content/1/1/4
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Principles behind combinatorial peptidomics
We have substituted the affinity purification step of the
peptidomics approach with quantitative depletion of the
peptide pools through chemical crosslinking of a subset of
peptides (through their amino acid side chains) to a solid
support. Chemical depletion reduces the complexity of a pep-
tide pool to a required degree to make it compatible with
direct MS detection. Because only those peptides that do
not contain an amino acid recognized by the amino acid
filter(s) remain in the mixture, the depleted peptide pools
contain peptides of reduced amino acid compositional com-
plexity. This further facilitates the analysis of mass spectra
produced by MALDI-TOF mass spectrometry and permits
a greater number of peptide peaks to be identified from a
mass spectrum. Unmodified peptides as well as proteins
generally contain up to 8 reactive groups. These include
six amino acid specific groups: Sulfhydryl groups of
Cysteines, Thioether groups of Methionines, Imidazolyl
groups of Histidines, Guanidinyl groups of Arginines,
Phenolic groups of Tyrosines and Indolyl groups of Tryp-
tophans (Figure 1). Any of these groups or combinations
thereof can be used to covalently immobilise respective
amino acids (and peptides which contain them) in a spe-
cific and fully predictable manner with respect to amino acid
content.  The remaining two reactive groups – amino
groups (H2N-) and carboxyl groups (HOOC-) are present
on every peptide as N- and C-terminal groups or epsilon
amino groups of Lysines or as parts or Aspartic acid and
Glutamic acid side chains. These groups may be used for
amino acid sequence- and content-independent manipu-
lations, for instance through chemical, radioactive, fluo-
rescent or isotopic labelling. Chemically reactive surfaces
(derivatised beads, for example) which covalently bind
amino acids in a side chain specific manner are referred to
as amino acid filters. Any combination of amino acid fil-
ters of various specificities or reactivities is possible. The
amino acid filtering (depletion) step may be repeated
using combinations of up to 6 filters (equivalent to a six-
dimensional separation, see Figure 2) or until the
complexity of the peptide pool and the amino acid com-
Six amino acids which contain chemically reactive side chains: Sulfhydryl groups in Cysteines (A), Guanidinyl groups in  Arginines (B), Phenolic groups in Tyrosines (C), Thioether groups in Methionines (D), Imidazolyl groups in Histidines (E) and  Indolyl groups of Tryptophans (F) Figure 1
Six amino acids which contain chemically reactive side chains: Sulfhydryl groups in Cysteines (A), Guanidinyl groups in 
Arginines (B), Phenolic groups in Tyrosines (C), Thioether groups in Methionines (D), Imidazolyl groups in Histidines (E) and 
Indolyl groups of Tryptophans (F).Journal of Nanobiotechnology 2003, 1 http://www.jnanobiotechnology.com/content/1/1/4
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Principles behind combinatorial peptidomics Figure 2
Principles behind combinatorial peptidomics. Sample is proteolytically digested, but the affinity purification step of the peptid-
omics approach [8] is substituted by quantitative depletion of the peptide pools through chemical crosslinking of a subset of 
peptides (through their amino acid side chains) to a solid support (e.g. derivatised beads, derivatised capillaries, etc). Sulfhydryl 
groups of Cysteines, Thioether groups of Methionines, Imidazolyl groups of Histidines, Guanidinyl groups of Arginines, Phe-
nolic groups of Tyrosines and Indolyl groups of Tryptophans can be used to covalently immobilise respective amino acids (and 
peptides which contain them) in a specific and fully predictable manner with respect to amino acid content. Any combination of 
such amino acid "filters" of various specificities or reactivities is possible (can be used sequentially or as a single "filter" with 
mixed specificity). Chemical depletion reduces the complexity of a peptide pool to a required degree to make it compatible 
with direct MS detection.Journal of Nanobiotechnology 2003, 1 http://www.jnanobiotechnology.com/content/1/1/4
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plexity of the remaining peptides is decreased to the
desired level (i.e. suitable for direct MS detection). A
quantitative chemical depletion principle can only be
applied to peptides since proteins are mostly globular
folded molecules, having a large fraction of the chemically
reactive amino acid residues buried deep in the protein
globule, thus preventing quantitative interactions. Com-
binatorial peptidomics relies on neither affinity reagents
of any kind (whether antibodies, antibody-mimics, their
fragments etc.) nor other chromatographic or electro-
phoretic separation techniques. Combinatorial peptid-
omics is the first generic methodology applicable to
protein expression profiling, which is independent of the
physical properties of proteins and does not require any
prior knowledge of the proteins. Alternatively, a specific
strategy based on combinatorial depletion, may be calcu-
lated and predicted for analysis of a known protein on the
basis of that protein sequence alone or, in the absence of
a reliable protein sequence, even the predicted amino acid
translation of an EST sequence.
Combinatorial approach
The Combinatorial approach includes two key stages,
which are described here in more detail. The first stage is
protein digestion. This can be achieved using a variety of
proteases or alternatively, chemical cleavage could be
used. Table 1 lists some of the most frequently used pro-
tein cleavage reagents. The second stage includes one or
more depletion steps. A number of amino acid side-chain
specific chemistries are available for use at this stage. Table
2 gives a few examples of the suitable amino acid side
chain-specific reagents. Some individual applications of
amino acid side chain specific chemistries can be found in
the literature. For example, the use of acetylimidazole as
Tyr- selective reagent [19–21], mercurial reagents or N-
ethylmaleimide as Cys- selective reagents [22–25], dike-
tones and phenylglyoxal as Arg- selective reagents [26,27],
diethylpyrocarbonate as a selective His-specific com-
pound [28]. Specific reaction of iodoacetate with methio-
nine was described in [29] and bromoacetyl compounds
for selective immobilisation of met-containing proteins
Table 1: Frequently used protein cleavage reagents
Enzymes Preferred cleavage site Approximate frequency
Ancrod Arg-X, Arg-Gly
Bromelain C-terminal to Lys, Ala and Tyr
Chymotrypsin C-terminal to hydrophobic residues, e.g., Phe, Tyr, Trp. Less sensitive 
with Leu, Met, Ala
Clostripain C-terminal to Arg residues 20
Collagenase N-terminal to Gly (X-Gly) in Pro-X-Gly-Pro
Elastase C-terminal to amino acids with small hydrophobic side chains
Endoproteinase Arg-C C-terminal to Arg residues 20
Endoproteinase Asp-N N-terminal to Asp and Cys 10
Endoproteinase Glu-C C-terminal to Asp and Glu 10
Endoproteinase Lys-C C-terminal to Lys 20
Factor Xa C-terminal to Arg in Gly-Arg-X
Ficin uncharged or aromatic amino acids
Follipsin Arg-X 20
Kallikrein C-terminal to Arg in (Phe-Arg-X or Leu-Arg-X)
Pepsin Broad specificity; preference for cleavage C-terminal to Phe, Leu, and 
Glu
7
Thermolysin N-terminal to amino acids with bulky hydrophobic side chains, e.g., Ile, 
Leu, Val, and Phe 5
Thrombin C-terminal to Arg
Trypsin C-terminal to Lys and Arg 10
V8 protease C-terminal to Glu, less active with Asp
Chemistry Preferred cleavage site
Cyanogen bromide Trp, (Met)
Formic acid Asp – Pro
HCl Asp-X, X-Asp
Hydroxylamine (alkaline pH) Asn – Gly
N-bromosuccinimide (NBS) or N- 
chlorosuccinimide
Trp
2-Nitro-5-thiocyanobenzoate (NTCB) CysJournal of Nanobiotechnology 2003, 1 http://www.jnanobiotechnology.com/content/1/1/4
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have been used by The Nest Group, Inc. (USA) in their
commercially available "Pi3-Met" reagent http://
www.nestgrp.com. Specific chemical crosslinking of the
tryptophan residues has been previously achieved using 2-
hydroxy-5-nitrobenzyl bromide [30].
The choice of proteases, crosslinking chemistries and of
their combinations is important and is determined by the
degree of depletion required and the frequency of the
amino acids being targeted. The frequency (F) with which
any amino acid occurs in proteins varies, but could
approximately be taken as 1/20 to illustrate the principle:
F = 1/20
Number of chances (C) to find any particular amino acid
"1" in the peptide containing n amino acids will therefore
be approximately equal:
C1 = n × F1 = n/20 (approx)
If our assumption (F = 1/20) is correct, each 20 amino
acid long peptide has on average one chance of being cov-
alently linked to any single "filter". If two filters are used
(in parallel or consecutively), then the number of chances
(C) to precipitate a peptide containing n amino acids, i.e.
to find any two amino acids "1" and "2" in such peptide
will be equal approximately:
C1+2 = n × F1 + n × F2 = n/10 (approx)
For any 3 amino acid filtering steps:
C1+2+3 = n × F1 + n × F2 + n × F 3 = n/7 (approx)
Any 4 amino acids:
C1+2+3+4 = n × F1 + n × F2 + n × F3 + n × F4 = n/5 (approx)
Any 5 amino acids:
C1+2+3+4+5 = n × F1 + n × F2 + n × F3 + n × F4 + n × F5 = n/
4 (approx)
Any 6 amino acids:
C1+2+3+4+5+6 = n × F1 + n × F2 + n × F3 + n × F4 + n × F5 + n
× F6 = n/3.5 (approx)
To deplete a complex peptide mixture by amino acid-spe-
cific sorption a different number of filters may be needed,
depending on the range of peptide lengths, which
depends on the cleavage technique. Using our assumption
that F = 1/20, a 3 – 4 amino acid long peptide may on
average be crosslinked once (i.e. has on average one
chance to be removed from the sample) through one of its
amino acid side chains using all six filters. The degree of
the depletion also depends on the average peptide length
(see Table 1). The degree of depletion needs to be adjusted
such as to yield a sufficiently depleted peptide pool suita-
ble for direct analysis by a mass spectrometer, i.e. having
~1000 peptides in the sample. Generally speaking, the
shorter the range of peptide fragment lengths, the greater
the number of filters required for the same degree of
depletion. The origin of the protein sample (whether
Table 2: Examples of amino acid side-chain specific chemistries
Reagents Group specificity Crossreactivity
α Haloacetyl compounds: Iodoacetate; α haloacetamides; bromotrifluoroacetone; 
N chloroacetyliodotyramine
Cys, His, Met, Tyr NH2 groups (slow at low pH)
N Maleimide derivatives: N ethylmaleimide (at pH < = 7) Cys NH2 groups (slow at low pH)
Mercurial compounds (most specific): p chloromercuribenzoate(PCMB)/p 
hydroxymercuribenzoate(PHMB) in H2O (optimum at pH 5, competitive dis-
placement possible)
Cys
Disulphide reagents (reversible): 5,5 dithiobis (2 nitrobenzoic acid) (DTNB); 4,4 
dithiodipyridine; methyl 3 nitro 2 pyridyl disulphide; methyl 2 pyridyl disulphide
Cys
N acetylimidazole Tyr NH2 groups (slow)
Diazonium compounds (optimum at pH9, unstable) Tyr, His NH2, Trp, Cys and Arg (slow)
Dicarbonyl compounds (pH > = 7): glyoxal; phenylglyoxal; 2,3 butanedione; 1,2 
cyclohexanedione
Arg Lys at pH < = 7
p toluenesulphonylphenyl alaninechloromethyl ketone (TPCK); p toluenesulpho-
nyllysine chloromethyl ketone (TLCK); Methyl-p-nitrobenzenesulphonate
His Cys
Diethylpyrocarbonate (reversible at pH > = 7) His (at pH4) NH2
2 hydroxy 5 nitrobenzyl bromide (HNBB) Trp
p nitrophenylsulphenyl chloride Trp, Cys
α Haloacetyl compounds Met at pH3; also Cys, His, Tyr NH2 groups (slow at low pH)Journal of Nanobiotechnology 2003, 1 http://www.jnanobiotechnology.com/content/1/1/4
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whole cellular proteome or partially purified narrow sub-
fraction, containing only few proteins) is another key fac-
tor determining the required degree of peptide depletion.
Results
Peptide depletion using Methionine-reactive amino acid 
filter
To illustrate the depletion principle we have used a mix-
ture of synthetic peptides (See Table 3) and Methionine-
reactive beads. Five of the ten peptides used contained
Methionine in different positions along their sequences.
The MALDI MS spectrum of the original peptide mixture
(incubated with no beads) is shown on Figure 3A. The ten
peaks corresponding to the peptides present in the mix-
ture are indicated. The same peptide mixture was incu-
bated with Methionine-reactive beads for depletion of all
Met-containing peptides by their irreversible cross-linking
to beads.
In affinity based systems the equilibrium state always
includes both free and bound analyte (i.e. peptide or pro-
tein), with their ratio being dependant on the dissociation
constant KD. Unlike an affinity recognition event, the
chemical reaction can be brought to completion more eas-
ily. Because of its quantitative character, the depletion by
irreversible chemical cross-linking is preferred to any
affinity-based separation because of the inherently incom-
plete character of the latter. Accordingly, the MS spectrum
of the depleted mixture, shown on Figure 3B, reveals no
Met-containing peptides. Thus the single depletion step
has reduced the complexity of this model peptide mixture
two fold.
Relative quantitation of depleted peptide mixtures
We have further investigated, using the same model pep-
tides and the Met-reactive bead system, whether the deple-
tion preserves quantitative differences between different
peptides (i.e. their concentrations). Three separate sam-
ples were prepared from the original and the depleted
peptide mixtures. Each such aliquot was treated and ana-
lysed in parallel using identical conditions and MS set-
tings. Three separate spectra from each of the samples
were obtained by accumulation of data from 400 laser
shots. Peak areas were measured for each peak on each
spectrum and average values were expressed as means.
The results obtained for the five peptides (without
Methionine) from the original and the depleted samples
are shown on Figure 4. The error bars indicate standard
deviations. The Figure 4 indicates that relative peptide
abundance for each individual peptide within each sam-
ple remains very similar between separate MS measure-
ments (with standard deviation mostly within 20% of
relative peak values). Figure 4 also demonstrates that the
chemical depletion step does not lead to major changes in
relative peak values of the remaining peptides (compare
open and filled bars on Figures 4A). This means that rela-
tive quantitation using mass spectrometry in conjunction
with the combinatorial approach is achievable without a
need for differential isotope labelling of peptides as in
ICAT [1] and that the depletion approach described can
be used for relative quantitation of protein expression lev-
els and other proteomic measurements.
Peptide labelling
Two or more samples originating from different tissues/
cells/etc can be subject to mass spectrometry at the same
time. To do this one must be able to distinguish the pep-
tide peaks which come from the different samples used.
Isotope labelling has been used before [1] for this pur-
pose. However, such labelling can also be achieved by
tagging peptides (or peptide pools) using non-identical
but similar chemical entities, having identical or closely
matching chemical and physical properties, but different
molecular masses. The Combinatorial approach allows
such labelling to be done through amino groups, prefera-
bly alpha-amino groups, or through carboxyl groups,
preferably alpha-carboxyl groups. The use of other reac-
tive groups is also possible, but less preferable as other
reactive side chains are more useful for combinatorial
depletion, whilst amino- or carboxyl- groups are present
on every peptide/protein and therefore represent the best
target for sequence-independent labelling. Unlike iso-
topic labelling, which is severely limited to a very few suit-
able isotopes, there is a vast choice of commercially
available materials for use as "chemical" labels. Mass dif-
ferences may be introduced into peptide pools either by
using the same amino- or carboxyl- group modifying
chemistry (but with varying side chains on the reagent
used), or using slightly different reagents whilst keeping
their side chains the same, or varying both. Examples of
such suitable amino-group reactive chemistries include:
aryl halides, aldehydes, ketones, alpha-haloacetyl (used at
pH > 7), N-maleimide (used at pH > 7) and derivatives, as
well as acylating reagents. Examples of carboxy-group
reactive chemistries include: diazoacetate esters, diazoa-
cetamides and carbodiimides. Figure 5A shows the mass
spectrum of the NFHQYSVEGGK peptide, used for differ-
ential labelling. The peptide was chemically labelled with
either 4-fluorophenyl-isothiocyanate (introduced ∆ m/z =
153, Figure 5B) or with 3,5-difluorophenyl-isocyanate
(introduced ∆ m/z = 155, Figure 5C). The fluorophenyl-
isocyanates and fluorophenyl-isothiocyanates are just two
of the numerous examples of acylating reagents with mass
differences introduced through modifying the reagents or
their own side chain modifications. The peptides could
alternatively be labelled through their carboxyl groups
using a large variety of reactive chemicals available. The
Discussion section further exemplifies available
alternatives.Journal of Nanobiotechnology 2003, 1 http://www.jnanobiotechnology.com/content/1/1/4
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Depletion of peptides using Methionine-reactive amino acid filter Figure 3
Depletion of peptides using Methionine-reactive amino acid filter. A – Untreated mixture containing 10 synthetic peptides (see 
Table 3). B – the same mixture following a Met-reactive chemistry mediated depletion (see Methods).Journal of Nanobiotechnology 2003, 1 http://www.jnanobiotechnology.com/content/1/1/4
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Discussion
Combinatorial approach
Characterization of the complement of expressed proteins
from a single genome is a central focus of the evolving
field of proteomics and can only be accomplished using a
high-throughput, generic process. The number of
expressed genes in a cell is estimated to be of the order of
10,000, resulting in up to 100,000 proteins, including
splice forms and post-translational modifications. Any
single protein could theoretically be identified by a single
peptide using a TOF or TOF/TOF MS, meaning that an
order of 100,000 non-identical "random" peptides may
be required to cover a complete cellular proteome. A sin-
gle mass spectrum is capable of resolving approximately
1000 different peptide peaks within the mass range of 500
to 3500 Da, corresponding to 5 to ~35 amino acid long
peptides (significantly larger numbers of peptides cannot
be resolved due to the resolution capabilities of TOF mass
spectrometry). Therefore only 10–20 such non-degener-
ate spectra (from non-identically depleted samples) may
be sufficient to reveal on average a single peptide from
each cellular protein, not including isoforms. Statistically
significant results, or detailed isoform analysis may
require more different spectra, e.g. a 96-well plate worth
of non-degenerate low-complexity samples. If splicing
and PTMs are of no concern and for pre-fractionated pro-
teomes, the number of representative spectra (whichever
way arising) may be much lower. Recent developments in
the field of the FT-MS capable of sub-ppm resolution (e.g.
the APEX series of machines developed at Bruker-Dalton-
ics, http://www.daltonics.bruker.com) may further reduce
the number of representative spectra required, ultimately
down to just few or one per proteome.
So far two main ideologies have been followed to decrease
the complexity of samples submitted to MS. One relied on
protein fractionation, followed by digestion and MS. In
another approach, samples are digested first, followed by
peptide fractionation. All fractionation techniques to date
have utilised physical properties of proteins/peptides (i.e.
size, charge, hydrophilicity/hydrophobicity, affinity inter-
actions, etc.) resulting in poorly reproducible, not very
quantitative techniques and expensive affinity reagents.
In the combinatorial approach presented here, the pep-
tide mixture is depleted in a quantitative and reproducible
manner by passage through one or more of the amino
acid side chain specific "filters". The depleted peptide
pools contain much fewer peptides, i.e. only those which
do not contain the targeted amino acids (i.e. not
crosslinked by the "filters") and can therefore be directly
subjected to TOF MS and TOF/TOF MS analysis. These
peptides are also of reduced amino acid complexity (e.g.
would only contain 14 amino acids if all six filters had
been used) thus facilitating peptide mass matching. The
existence of the six reactive groups provides for the use of
up to six independent amino acid covalent filters (with
many more different chemistries available), thus bringing
the total number of different filter combinations to 63.
Table 4 lists possible combinations of such filters. Using
all such filters simultaneously will result in a maximum
possible depletion and should preferably be used for the
most complex peptide mixtures, e.g., whole cell pro-
teomes. Using individual amino acid "filters" or subsets of
"filters" may be preferable for low-complexity protein
mixtures, containing fewer individual proteins, e.g., sim-
ple micro-organism proteomes, or protein fractions
resulting from pre-fractionating of more complex pro-
teomes. The depletion degree may be varied either by
changing the number of filters used or through the length
of peptide fragments (longer fragments are more likely to
be crosslinked due to higher probabilities of amino acid
occurrences in long peptides). Nearly 20 different diges-
tion specificities available (see Table 1) combined with up
to 63 crosslinker combinations will result in hundreds of
potential combinations, providing a sufficient number of
Table 3: Synthetic peptides used in this study
Peptide sequence* Methionine present m/z Seq. ID
RPPQTLSR no 1293.56 1
NLSPDGQYVPR no 1584.83 6
SANAEDAQEFSDVER no 2007.13 9
NFHQYSVEGGK no 1604.82 11
LERPVR no 1108.38 16
VFAQNEEIQEMAQNK yes 2118.43 4
DLPLLIENMK yes 1524.92 8
ETYGEMADCCAK yes 1659.95 19
FIMLNLMHETTDK yes 1932.37 5
DLVTQQLPHLMPSNCGLEEK yes 2592.07 13
* All peptides were biotinylated at their N termini.Journal of Nanobiotechnology 2003, 1 http://www.jnanobiotechnology.com/content/1/1/4
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Relative quantitation of peptides Figure 4
Relative quantitation of peptides. A – Five peptides containing no Methionines (see Table 3) prior to (open bars) and after the 
depletion using Met-reactive beads (filled bars). B – Five peptides containing Methionines (see Table 3) prior to (open bars) and 
after the depletion using Met-reactive beads. No Met-containing peptides were detected in the depleted samples. Bar heights 
(both panels) represent averaged peak values detected (+/- STDEV, n = 9). Peptides are identified by their Seq IDs below each 
bar (on both panels).Journal of Nanobiotechnology 2003, 1 http://www.jnanobiotechnology.com/content/1/1/4
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non-identical depleted peptide pools of the low complex-
ity to achieve the required total number of peptides. The
combinatorial approach may be further streamlined by
predicting the optimal combinations (digestion +
crosslinker) if protein sequence information is available.
The Combinatorial approach is inherently tolerant to
experimental artefacts arising from the incomplete diges-
tion (usually the enzymatic and therefore least predictable
step of the technique, and a course of complications in
other peptidomics applications). The products of incom-
plete digestion will be mostly eliminated from the sam-
ples, because for longer protein fragments, the chances of
any single reactive amino acid being present in their
sequences is much higher. This feature further reduces the
complexity of the Mass Spectra and improves signal/noise
ratio.
Depletion versus enrichment
The combinatorial peptidomics approach described so far
has relied on depletion as the means to reduce complexity
of the peptide mixture. As opposite to depletion, the com-
binatorial approach can also be carried out using enrich-
ment selection techniques (i.e. by retaining peptides
containing the required amino acids, i.e. Cysteines,
Methionines, Histidines, Arginines, Tyrosines and/or
Tryptophans, individually or in combinations). In such
an embodiment, the peptide mixture is passed through
the selected amino acid filter which crosslinks or binds
peptides containing the respective amino acid. The filter
assembly is then washed to remove unbound peptides
and the chemical crosslink is cleaved in order to free the
bound peptides. The protocol can be repeated using one
or more of the other amino acid filters. Both depletion
Differential mass labelling of the NFHQYSVEGGK peptide Figure 5
Differential mass labelling of the NFHQYSVEGGK peptide. A – mass spectrum of the unmodified peptide. B – mass spectrum 
of the same peptide modified with 4-fluorophenyl-isothiocyanate (introduced ∆ m/z = 153). C – mass spectrum of the same 
peptide modified with 3,5-difluorophenyl-isocyanate (introduced ∆ m/z = 155).
Table 4: Amino acid side chain specific "filters"
Average Peptide length
in mixture
Number of amino acid filters required for near 
complete depletion
Maximum number of possible combinations of 
amino acid filters
20 1 6 (i.e. either"1" or "2" etc., etc.)
10 2 15 (i.e. either "1+2" or "1+3" etc.)
73 20 (i.e. either "1+2+3" or "1+2+4" etc.)
54 15 (i.e. "1+2+3+4" or "1+2+3+5" etc.)
45 6 (i.e. "all but 1" or "all but 2" etc.)
36 1 (i.e. "1+2+3+4+5+6")Journal of Nanobiotechnology 2003, 1 http://www.jnanobiotechnology.com/content/1/1/4
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and enrichment reduce the complexity of the sample and
will result in complementary non-degenerate peptide
pools. However these approaches have a few characteristic
differences (summarised in Table 5). Most significantly,
the depletion approach allows for a more straightforward
and faster route, suitable for peptides of 10 amino acids
and longer, while the slower enrichment approach pro-
vides a better alternative for shorter peptides (e.g. 10
amino acids or less). Depletion is advantageous over
enrichment in that it also decreases the compositional
complexity of the remaining peptide pool, thus further
facilitating analysis, such as the analysis of the mass spec-
tra. Another important difference includes the resistance
of the depletion approach towards incompletely digested
peptides. Since these will generally be of increased
lengths, the products of incomplete digestion (a major
course of complications in other peptidomics applica-
tions) will be mostly eliminated from the depleted sam-
ples (due to longer peptides having higher chance of
being crosslinked).
Labelling
Differential labelling may be very useful if absolute quan-
titation is required (as opposed to relative quantitation).
This can be exemplified further as follows. The acylating
reagents, such as described in Section 2.3 above, could, for
example, be modified with either Fluorine, Chlorine, Bro-
mine or Iodine (i.e. use bromine-isothiocyanate versus
iodine-isothiocyanate). Alternatively these could be
"mono-", "di-" or "tri-" etc. modifications (i.e. use fluor-
ophenyl-isothiocyanate vs. difluorophenyl-isothiocy-
anate) or the amino-reactive chemistry could be modified
itself (i.e. use isocyanate vs. isothiocyanate), or the
isocyanates could be derivatised differently (i.e. isocy-
anate vs. phenyl-isocyanates etc). A combination of the
above could lead to 100s of differential molecular tags (far
exceeding the capabilities of isotope labelling) by using
isocyanates or derivatives alone. The ∆ m/z mass differ-
ence introduced could be made as low as 2 (1 is less pref-
erable due to potential difficulties in resolving naturally
occurring isotopes of the peptides), as in the case with 4-
fluorophenyl-isothiocyanate (∆ m/z = 153) and 3,5-dif-
luorophenyl-isocyanate (∆ m/z = 155), and there is prac-
tically no limit on the upper range of the mass differences.
However, larger mass differences will complicate the reso-
lution of corresponding peptides in complex mixtures and
are therefore less preferable. The use of chemical labelling
allows much smaller ∆ m/z to be used and the number of
chemical labels is not limited by the number of available
isotopes (as in ICAT method, known in the field). Also
more than two complex peptide mixtures could be differ-
entially labelled and analysed simultaneously unlike the
Table 5: Comparison of the depletion and enrichment approaches to combinatorial peptidomics
Depletion approach Enrichment approach
1. Individual steps per each "filtering" stage 1 step process, i.e. bind to beads (beads 
discarded)
3 step process, i.e. bind to beads, wash and 
elute
2. Number of combinations using 6 amino acid 
filters
63 63
3. Range of suitable peptide lengths Longer peptides require less "filtering" stages 
(i.e. 10 or more amino acid residues preferred)
Shorter peptides require less "filtering" 
stages (i.e. 10 or less amino acid residues 
preferred)
4. Complexity of peptide mixtures Decreased Decreased
5. Amino acid compositional complexity of the 
remaining peptides
Decreased (by the number of "filters" used) Not changed (20 amino acids)
6. Quantitative analysis A single-stage depletion is more straightfor-
ward and quantitative than a triple-stage 
enrichment
Enrichment approach is less straightforward 
and robust than the depletion
7. Scaling up Possible (larger "filters" or consecutive stages) Possible (larger "filters" or parallel reactions)
8. Scaling down Possible (low fmol level MS sensitivity requires 
high pmol filter binding capacities)
Especially suitable : low fmol level MS sensitivity 
requires fmol binding capacities
9A. Limitations (overloading) Large binding capacity of the "filters" is crucial – 
overloading will allow all peptides to pass the 
"filter"
Overloading of the "filters" is not an issue, 
excess of sample may be applied
9A. Limitations (incompletely digestion) Products of incomplete digestion will be mostly 
eliminated
Products of incomplete digestion will be mostly 
retained and may interfere with the down-
stream purification and analysis steps
10. Nano-applications Problematic due to limitation (see above) – 
excess of binding sites required to maintain effi-
cient separation. Suitable for micro-fluidic 
applications
Suitable for nano-applications, since smaller 
number of binding sites required (compared to 
depletion strategy)Journal of Nanobiotechnology 2003, 1 http://www.jnanobiotechnology.com/content/1/1/4
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ICAT method [1] or D0-/D3-per-methyl esterification
approach [31] or acrylamide/deuterated acrylamide label-
ling method [32] (two samples only in each method). In
addition to the ability to easily choose the desired ∆ m/z,
the chemical modifications allow the mass range of the
analysed peptides to be shifted upwards. So the low
molecular weight peptides, otherwise subject to interfer-
ence from MALDI matrix related species, could be shifted
into high MW range (in addition to, or instead of being
differentially labelled).
High throughput and nano-applications
Combinatorial peptidomics is suitable for use with a vari-
ety of platforms, including traditional systems (column-
based co-IP), arrayed affinity reagents (antibody microar-
rays, e.g. on MALDI plates) and a variety of micro- and
nano-fluidic applications. Except for a few obvious and
easily accepted reasons for miniaturisation, such as
increasing the throughput of an assay by packing more
reaction chambers into the same volume, and decreasing
the assays cost, miniaturisation is especially suitable if
combinatorial peptidomics approaches are sought. Minia-
turisation has the potential to increase the reaction kinet-
ics due to much smaller reaction volumes (and therefore
faster reagent diffusion times) and significantly increased
surface to volume ratios. This is especially applicable to
combinatorial peptidomics, since both depletion and
enrichment involves immobilising amino acids and pep-
tides onto the solid surfaces. Truly miniature applications
do not require the use of porous resins and careful selec-
tion of pore sizes, since a high surface to volume ratio of
a small capillary channel, which is also easier to control,
may be sufficient.
The Enrichment strategy, as opposed to Depletion, would
better suit nano-fluidic or other applications where the
size of reaction chambers matters (e.g. chips, micro- or
nano-fluidics devices, etc). Since no excess of binding sites
is required and because of its stability towards sample
overloading, the overall size of such a device could be
made smaller if the enrichment approach is used. For
example, if only a single enrichment step is used, and
peptide capture is totally reversible, then as few as low
femtomole amounts of crosslinking chemistries may be
required to retain peptide amounts sufficient for MS
detection. Overloading of such a "filter" should not lead
to an increase in the retained and released peptides, since
the binding capacity of such a "filter" is limited. Although
depletion may be performed faster, the overall binding
capacity of a single "depletion filter" may need to be
order(s) of magnitude larger to secure the reaction kinet-
ics and to secure stability against sample overloading.
Conclusions
Modern proteomics aims to systematically analyse pro-
teins for their identity, quantity and function and there-
fore requires new more generic and truly multiplex
approaches for protein research. The combinatorial pepti-
domics approaches presented in this manuscript rely on
the quantitative depletion or enrichment of peptide pools
by chemical crosslinking through amino acid side chains.
Chemical depletion reduces both the complexity of a pep-
tide pool and the amino acid compositional complexity
to a degree required to allow direct MS analysis. The com-
binatorial approach utilises commonly used proteolytic
digestion techniques and widely available chemistries,
many of them being well documented. The combinatorial
peptidomics approach allows the determining of the
composition of a protein mixture by assaying peptides
directly from crude tryptic digests without using antibod-
ies or any other affinity selection and therefore enables
protein identification on a proteome-wide scale. Using all
possible combinations of enzymatic/chemical protein
digestion methods plus all combinations of the adsorp-
tion chemistries may allow thousands of peptides to be
identified. The method presented greatly advances the
effort of identifying all cellular proteins in "one go". The
simplicity and predictability of the combinatorial
approach (i.e. on the basis of protein sequence alone)
provides for optimization of strategies for quantitative
analysis of known proteins by using calculated and pre-
dicted combinations of digestion and separation features.
Combinatorial peptidomics is suitable for studying both
novel protein targets and for routine diagnostic applica-
tions. Combinatorial peptidomics is the first generic pro-
teomics technology, reliant on the information content of
proteins and peptides for their separation and analysis.
The Combinatorial peptidomics approach compares to
existing affinity based separation systems just as digital
signal processing compares to analogue systems – it forms
the basis of the high throughput proteomics technologies
of the future.
Materials and Methods
Peptide depletion using Methionine-reactive amino acid 
filter
All peptides were obtained from SIGMA-Genosys. The
Met-reactive beads (obtained from The Nest Group,
Southborough, MA, USA) were activated as follows: beads
from one "Pi3" isolation pack (approx 10 ul dry settled
volume) were washed ×5 times with ×400 ul Methanol,
followed by ×3 washes with 10% Acetic Acid using a spin
column. Following washing, the beads were resuspended
in 400 ul 10% Acetic Acid and transferred to a 1.5 ml
microcentrifuge tube. Beads were precipitated by centrifu-
gation and the supernatant (Acetic Acid) was removed.
Peptide samples were prepared as follows: 75 ul of a pep-
tide mixture (Table 3), containing approximately 75 ugJournal of Nanobiotechnology 2003, 1 http://www.jnanobiotechnology.com/content/1/1/4
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peptides in total, was mixed with 25 ul of glacial Acetic
Acid. The peptide mixture was divided into two 50 ul aliq-
uots. One aliquot was transferred to the microcentrifuge
tubes with the activated Met-reactive beads, whilst
another aliquot was incubated without beads. Samples
were left at 22°C for 18 hours. Following the incubation
tube with beads was spun for 1 min at 10,000 RPM in a
microcentrifuge and supernatant was transferred to a fresh
tube.
Mass spectrometric analysis was performed as described
previously [7,8]. Briefly, 5 ul aliquots were taken from
each sample. The volume was then made up to 10 ul in
0.1 % TFA and the overall amount of TFA adjusted to 0.1
%. Each sample was bound to a Zip Tip, washed in 0.1 %
TFA and eluted in 1 ul of a solution containing alpha-
cyano-4-hydroxycinnamic acid (~2.5 mg/ml in 3:2 meth-
anol/0.1% TFA) and deposited directly onto a target for
MALDI-TOF-MS. All spectra were acquired in the standard
reflector mode of a Voyager DE STR (Applied Biosystems,
Foster City, CA). Four hundred laser shots were fired and
the resulting mass spectra were averaged to produce each
final trace.
For the relative quantitation study each graph was
obtained from 3 separate mass spectra taken from three
separately prepared samples (9 spectra altogether) for
peptide mixtures both prior to depletion and after deple-
tion with Met-reactive beads. All spectra were obtained
under identical MS settings and all other details were the
same. Values for each individual peptide were calculated
as individual peak areas taken relative to the average peak
areas from the 5 peptides (not-containing Met) for each
separate spectrum. The normalised values were then plot-
ted as means for each peptide (see above, +/- STDEV, n =
9) on both plots.
Labelling
Figure 5A shows the mass spectrum of the NFHQYS-
VEGGK peptide, used for differential labelling. The
labelling was done with either 4-fluorophenyl-isothiocy-
anate or 3,5-difluorophenyl-isocyanate. Labelling was car-
ried out at 4°C. The peptide solution (5 ul) was added to
85 ul of H2O and the buffer concentration was adjusted to
20 mM Na-CO3 (pH9.5). Following that 10 ul of 10%
solution of acylating reagents in DMSO was added to the
peptide, mixed and incubated overnight. The peptide was
chemically labelled with 4-fluorophenyl-isothiocyanate
(introduced ∆ m/z = 153), see Figure 5B and with 3,5-dif-
luorophenyl-isocyanate (introduced ∆ m/z = 155), see
Figure 5C.
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